Strategic Partnership with JPM

Occasionally, and as part of the technology transfer service, JPM would assume the role of the strategic partner, and would obtain equity in the receiving company in return for technology transfer. This will only happen in cases where JPM can see a clear strategic benefit from partnering on the long term.

JPM currently holds equity in the following companies, gained in lieu of knowhow:

  • Azel Pharmaceutical Shareholding Company, Eritrea
  • SAIPh (Société Arabe des Industries), Tunisia
  • Belvitfarm, Belarus
  • Opi-Pharma (El-Obour Modern Pharmaceutical Industries Company), Egypt
  • TAPHCO (Tassili Arab Pharmaceutical Co., not in operation), Algeria
  • Final Farmaceutica, Mozambique
Generic Drug
JPM Brand
© 2017 Jordanian Pharmaceutical Manufacturing Co. PLC. All Rights Reserved Powered By: ESKADENIA Software